Lüscher TF - Search Results

1

International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.

Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C. Ghadri JR, et al. Among authors: luscher tf. Eur Heart J. 2018 Jun 7;39(22):2032-2046. doi: 10.1093/eurheartj/ehy076. Eur Heart J. 2018. PMID: 29850871 Free PMC article.

2

Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease.

Lüscher TF. Lüscher TF. Eur Heart J. 1989 Sep;10(9):847-57. doi: 10.1093/oxfordjournals.eurheartj.a059580. Eur Heart J. 1989. PMID: 2680493 Review.

3

Endothelin: culprit or bystander in Addison's disease?

Ruschitzka FT, Lüscher TF. Ruschitzka FT, et al. Among authors: luscher tf. Eur J Endocrinol. 1996 Dec;135(6):645-8. doi: 10.1530/eje.0.1350645. Eur J Endocrinol. 1996. PMID: 9025703 No abstract available.

4

Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?

Ruschitzka FT, Lüscher TF. Ruschitzka FT, et al. Among authors: luscher tf. Am Heart J. 1997 Aug;134(2 Pt 2):S31-47. doi: 10.1016/s0002-8703(97)70007-3. Am Heart J. 1997. PMID: 9313622 Review.

5

The endothelium in coronary artery disease.

Ruschitzka FT, Noll G, Lüscher TF. Ruschitzka FT, et al. Among authors: luscher tf. Cardiology. 1997;88 Suppl 3:3-19. doi: 10.1159/000177500. Cardiology. 1997. PMID: 9397288 Review.

6

Combination of ACE inhibitors and calcium antagonists: a logical approach.

Ruschitzka FT, Noll G, Lüscher TF. Ruschitzka FT, et al. Among authors: luscher tf. J Cardiovasc Pharmacol. 1998;31 Suppl 2:S5-16. doi: 10.1097/00005344-199800002-00002. J Cardiovasc Pharmacol. 1998. PMID: 9605596 Review.

7

Angiotensin converting enzyme inhibitors and vascular protection in hypertension.

Ruschitzka F, Noll G, Lüscher TF. Ruschitzka F, et al. Among authors: luscher tf. J Cardiovasc Pharmacol. 1999 Aug;34 Suppl 1:S3-12. doi: 10.1097/00005344-199908001-00002. J Cardiovasc Pharmacol. 1999. PMID: 10499558 Review.

8

Working under pressure: the vascular endothelium in arterial hypertension.

Spieker LE, Noll G, Ruschitzka FT, Maier W, Lüscher TF. Spieker LE, et al. Among authors: luscher tf. J Hum Hypertens. 2000 Oct-Nov;14(10-11):617-30. doi: 10.1038/sj.jhh.1001012. J Hum Hypertens. 2000. PMID: 11095155 Review.

9

Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension.

Quaschning T, Ruschitzka F, Shaw S, Lüscher TF. Quaschning T, et al. Among authors: luscher tf. Hypertension. 2001 Feb;37(2 Pt 2):801-5. doi: 10.1161/01.hyp.37.2.801. Hypertension. 2001. PMID: 11230376

10

Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?

Spieker LE, Noll G, Ruschitzka FT, Lüscher TF. Spieker LE, et al. Among authors: luscher tf. J Am Coll Cardiol. 2001 May;37(6):1493-505. doi: 10.1016/s0735-1097(01)01210-4. J Am Coll Cardiol. 2001. PMID: 11345356 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,635 results

Search Page

Filters